Samsung BioLogics, Pfizer deny report on COVID-19 vaccine production in S.Korea

Samsung BioLogics Co Ltd and Pfizer Inc on Wednesday denied a report that they were working together to produce in South Korea a COVID-19 vaccine developed by the U.S. drugmaker. The Korea Economic Daily reported earlier that the biotech arm of Samsung Group had been revamping production lines at its plant in Songdo to produce the Pfizer vaccine, which was jointly developed by the German BioNTech. The report quoted an unnamed high-level government official as saying the plant had the capacity to make up to 1 billion doses per year and production could start as early as in August.